Enhabit Acquires Southwest Florida Home Care’s Fort Meyers, Florida Location; Terms Not Disclosed
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced the acquisition of Southwest Florida Home Care, Inc.'s home health agency located in Fort Meyers, Fla.
"We are excited
Samsara Sees Q4 Revenue $170M-$172M Vs $161.26M Est., Adj. EPS $(0.06)-$(0.05) Vs $(0.06) Est.; Sees FY23 Revenue $636M-$638M Vs $612.87M Est., Adj. EPS $(0.17)-$(0.16) Vs $(0.21) Est.
Financial Outlook
Our guidance includes GAAP and non-GAAP financial measures. For the fourth quarter and fiscal year 2023, Samsara expects the
UiPath Q3 Adj. EPS $0.05 Beats $(0.03) Estimate, Sales $262.74M Beat $248.51M Estimate
UiPath (NYSE:PATH) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.03) by 266.67 percent. The company reported quarterly sales of $262.74 million which beat the analyst
Veeva Systems Q3 EPS $1.13 Beats $1.07 Estimate, Sales $552.35M Beat $546.04M Estimate
Veeva Systems (NYSE:VEEV) reported quarterly earnings of $1.13 per share which beat the analyst consensus estimate of $1.07 by 5.61 percent. This is a 16.49 percent increase over earnings of $0.97 per share from the same
Ulta Beauty Q3 EPS $5.34 Beats $4.15 Estimate, Sales $2.34B Beat $2.21B Estimate
Ulta Beauty (NASDAQ:ULTA) reported quarterly earnings of $5.34 per share which beat the analyst consensus estimate of $4.15 by 28.67 percent. This is a 35.53 percent increase over earnings of $3.94 per share from the
Israeli Ministry Of Health Clears Way For Human Trials Of Allocetra
The Israeli Ministry of Health (MOH) approved a Phase I/II trial of Enlivex Therapeutics Ltd.’s (NASDAQ:ENLV) proprietary immunotherapy drug-candidate AllocetraTM.
AllocetraTM is a cell therapy that uses healthy